This test — 12 years in the making — uses machine-learning to help doctors rule in or rule out a suspected multiple sclerosis diagnosis within 7 days, with more than 90% accuracy. This is a game changer that will diagnose faster, treat sooner and improve lives.
“The 90 percent accuracy rate of IsolateMS should give providers and patients a great deal of confidence in their results,” said IQuity CEO Dr. Chase Spurlock. “This test augments existing clinical practice and eliminates the period of uncertainty that can accompany an MS diagnosis. IsolateMS allows patients and providers to begin discussing next steps immediately.”
There are about 15,000 new MS diagnoses every year, but some patients have to go through months or years of harmful symptoms and testing before reaching a confirmed diagnosis. This test could help doctors get the answers they need early to start the right treatment plans for those patients sooner.
I will be interviewing IQuity’s CEO, Dr. Chase Spurlock and will include your questions. Let me know what you want to know about IQuity and Isolate MS and I will pass it on.
Would you take a blood test to determine if you have MS?